Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Clinical evidence The SURMOUNT-1 trial found that participants without diabetes lost an average of 22.5% of body weight at the 15 mg dose after 72 weeks
How can supplement manufacturers serve this evolving market
A clinician can help compare approved options based on diagnosis, medical history, current medicines, tolerability, pregnancy plans, and coverage or cash-pay realities
Blogs Retatrutide vs Tirzepatide vs Semaglutide: Mechanism and Research Comparison By Clark Jones, PhD, Velora Research Written and reviewed for scientific accuracy by Clark Jones, PhD ([ORCID 0009-0005-9356-0297]( Last reviewed 2026-05-28
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
